What is the current Cytomegalovirus ELISA Kits market size?

The Cytomegalovirus ELISA Kits market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Cytomegalovirus ELISA Kits market?

Key drivers include rising awareness of Cytomegalovirus infections and advancements in diagnostic technologies.

What challenges does the Cytomegalovirus ELISA Kits market face?

The market faces challenges such as high costs of kits and limited accessibility in developing regions.

Which regions are leaders in the Cytomegalovirus ELISA Kits market?

North America and Europe are currently the leading regions in the market due to high awareness and infrastructure.

Who are the top companies in the Cytomegalovirus ELISA Kits market?

Top companies include Roche, Abbott, and Thermo Fisher, which offer a wide range of diagnostic kits.

What future opportunities exist for the Cytomegalovirus ELISA Kits market?

Future opportunities include emerging markets and the development of point-of-care diagnostic kits.

How does technology impact the Cytomegalovirus ELISA Kits market?

Advances in technology have improved the sensitivity and specificity of ELISA kits, driving market growth.

What is the regulatory landscape for the Cytomegalovirus ELISA Kits market?

The market is regulated by authorities such as the FDA and CE, which ensure compliance with safety standards.

What is the future outlook for the Cytomegalovirus ELISA Kits market?

The future outlook is positive, with increasing demand for diagnostic kits driving market expansion.

Cytomegalovirus ELISA Kits Market Intelligence Report 2026 — Updated June 2026

Cytomegalovirus ELISA Kits by Application (Laboratory, Colleges, Others), by Types (IgG, IgM), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Cytomegalovirus ELISA Kits Market Size | CAGR 7.8 Forecast 2033

Cytomegalovirus ELISA Kits Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cytomegalovirus ELISA Kits Market Overview

The Cytomegalovirus ELISA Kits market refers to the industry that provides diagnostic kits for detecting Cytomegalovirus (CMV) infections. The relevance of this market lies in its critical role in facilitating the diagnosis and treatment of CMV infections, which can have severe consequences if left undetected. The Cytomegalovirus ELISA Kits market size was estimated to be around $543.8 million in 2021 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The growth outlook for this market is positive, driven by increasing demand for diagnostic kits, advancements in technology, and the expansion of the healthcare industry. The market forecast suggests that the industry will experience significant growth, with the global Cytomegalovirus ELISA Kits market size expected to reach $1.03 billion by 2033. Key forces shaping the industry include technology shifts, regulatory requirements, and competitive intensity.

Loading chart…

The largest region in the Cytomegalovirus ELISA Kits market is North America, driven by the presence of major diagnostic kit manufacturers and a well-established healthcare infrastructure. The fastest-growing region is expected to be the Asia-Pacific, driven by increasing demand for diagnostic kits, rising healthcare expenditure, and government initiatives to improve healthcare infrastructure. The Cytomegalovirus ELISA Kits market is expected to experience significant growth during the forecast period, driven by advancements in technology, increasing demand for diagnostic kits, and the expansion of the healthcare industry. The market is highly competitive, with major players competing on the basis of product quality, price, and distribution networks. The industry is also subject to regulatory requirements, with manufacturers required to comply with strict regulations and guidelines.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MyBioSource; Biomatik; BosterBio; Abbexa; DEMEDITEC Diagnostics; United States Biological; Biorbyt; Novus Biologicals; IBL; XpressBio; Abnova Corporation; Wuhan Fine Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cytomegalovirus ELISA Kits market is poised for significant growth, driven by increasing demand for diagnostic solutions and advancements in medical technology. The market dynamics are shaped by various factors, including the rising prevalence of Cytomegalovirus infections, growing awareness about the importance of early diagnosis, and the expanding applications of ELISA kits in research and clinical settings.

Growth Drivers2 items

The Cytomegalovirus ELISA Kits market size is expected to expand due to the increasing adoption of ELISA kits in hospitals, clinics, and research institutions, driven by their high sensitivity, specificity, and convenience.

Advances in technology, such as the development of automated ELISA systems, are anticipated to further drive the growth forecast of the Cytomegalovirus ELISA Kits market, enabling faster and more accurate test results.

Restraints2 items

The high cost of ELISA kits, particularly those with advanced features, may limit their adoption in resource-constrained settings, restraining the growth of the Cytomegalovirus ELISA Kits market.

Stringent regulatory requirements, such as those related to the validation and verification of ELISA kits, may pose challenges for manufacturers, potentially slowing down the Cytomegalovirus ELISA Kits market size expansion.

Opportunities2 items

The increasing demand for point-of-care diagnostic solutions presents opportunities for manufacturers to develop innovative, user-friendly ELISA kits that can be used in decentralized settings, driving the growth forecast of the Cytomegalovirus ELISA Kits market.

The expanding applications of ELISA kits in research and clinical trials are expected to create new avenues for growth, as these kits can be used to study the immune response to Cytomegalovirus infections and develop new treatments.

Challenges2 items

The Cytomegalovirus ELISA Kits market is highly competitive, with several established players, making it challenging for new entrants to gain market share and for existing manufacturers to differentiate their products.

The need for standardization of ELISA kits and testing protocols may pose a challenge, as different manufacturers may have varying standards, potentially affecting the accuracy and comparability of test results.

Market Segmentation

Loading chart…

The Cytomegalovirus ELISA Kits market can be segmented based on application, which includes diagnosis, research, and blood screening. The diagnosis segment holds a significant share of the market, driven by the increasing prevalence of cytomegalovirus infections. The research segment is also expected to grow, owing to the rising demand for ELISA kits in laboratories and research institutions. Understanding the Cytomegalovirus ELISA Kits segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

In terms of types, the Cytomegalovirus ELISA Kits market can be categorized into indirect ELISA, direct ELISA, and sandwich ELISA. Indirect ELISA is the most commonly used type, accounting for a significant share of the market. This is due to its high sensitivity and specificity, making it a preferred choice for detecting cytomegalovirus antibodies. The sandwich ELISA type is also gaining traction, driven by its ability to detect multiple analytes simultaneously. Analyzing the market taxonomy of Cytomegalovirus ELISA Kits is essential to understand the dynamics of each segment and their contributions to the overall market size.

Cytomegalovirus ELISA Kits Segmentation Breakdown7 items

Application

Laboratory

Colleges

Others

Types

IgG

IgM

Regional Insights

Loading chart…

The Cytomegalovirus ELISA Kits market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by policies supporting research and development, a strong ecosystem, and significant investments in healthcare. Asia Pacific is fueled by a large and growing population, increasing adoption of diagnostic technologies, and rising investments in healthcare infrastructure. Latin America and Middle East & Africa are expected to be driven by growing demand for diagnostic solutions, improving infrastructure, and increasing policies supporting healthcare development.

The regional forecast indicates that Asia Pacific will experience the highest Cytomegalovirus ELISA Kits market growth, driven by emerging economies and increasing demand for diagnostic solutions. North America and Europe will continue to dominate the market, while Latin America and Middle East & Africa will experience steady growth, driven by improving infrastructure and increasing adoption of diagnostic technologies.

Competitive Landscape

The Cytomegalovirus ELISA Kits market exhibits a moderately consolidated structure, with a mix of global players and local/regional companies. The Cytomegalovirus ELISA Kits competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and cost advantages.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technological advancements, service model innovation, and channel strength. The following companies illustrate different strategic focuses:

MyBioSource: regional expansion

Biomatik: premium pricing

BosterBio: innovation pipeline

Abbexa: local manufacturing

DEMEDITEC Diagnostics: OEM tie-ups

United States Biological: vertical integration

Key Cytomegalovirus ELISA Kits Companies12 items

MyBioSource

Biomatik

BosterBio

Abbexa

DEMEDITEC Diagnostics

United States Biological

Biorbyt

Novus Biologicals

IBL

XpressBio

Abnova Corporation

Wuhan Fine Biotech

Market Ecosystem

The Cytomegalovirus ELISA Kits ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where manufacturers and integrators create the ELISA kits; and downstream, where channels and end users interact. Value is created and captured at each stage, with technology providers and suppliers influencing the quality and cost of the kits, and end users driving demand.

Raw material/component suppliers — provide essential reagents

OEMs / manufacturers — produce ELISA kits

Technology providers — develop underlying assay technologies

System integrators / EPCs — assemble and package kits

Distributors / channel partners — supply kits to end users

End users / buyers — purchase and utilize ELISA kits

Regulators/standards bodies — establish testing and validation standards

In the Cytomegalovirus ELISA Kits ecosystem, control points are primarily held by regulators and end users, as they influence adoption through standards and purchasing decisions. Dependency risks arise from input constraints, such as the availability of high-quality antibodies, and standards approvals, which can impact kit development and sales. Switching costs are relatively low, but partnerships and interoperability requirements can create barriers to entry for new manufacturers. As part of a broader value chain analysis, understanding these dynamics is crucial for navigating the Cytomegalovirus ELISA Kits ecosystem.

Recent Industry Insights

The Cytomegalovirus ELISA Kits industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading diagnostic companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also occurred, with major players expanding their product portfolios to cater to the growing demand for Cytomegalovirus ELISA Kits.

Furthermore, several product launches have taken place, introducing advanced technologies and improved sensitivity in Cytomegalovirus detection. Regulatory changes, such as updated guidelines for diagnostic kit approval, have also impacted the industry. Additionally, a shift in consumer and enterprise trends towards preventive healthcare has fueled the demand for Cytomegalovirus ELISA Kits, with companies responding by investing in funding rounds or expansions to enhance their market presence.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view of the Cytomegalovirus ELISA Kits market. The market attractiveness is moderate due to increasing demand for diagnostic kits. The competitive intensity is high, with several key players competing for market share. Looking at the long-term Cytomegalovirus ELISA Kits market outlook, I foresee steady growth driven by advancements in medical technology and rising awareness of cytomegalovirus infections.

The innovation landscape is evolving, with research focused on developing more accurate and efficient ELISA kits. However, the demand–supply balance may be affected by fluctuations in raw material availability. Key risk factors include regulatory changes and intense competition. Overall, decision-makers should consider these factors when navigating the Cytomegalovirus ELISA Kits market.

11 items

1. Executive Summary

2. Cytomegalovirus ELISA Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cytomegalovirus ELISA Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cytomegalovirus ELISA Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Laboratory

6.1.2. Colleges

6.1.3. Others

6.2. Global Cytomegalovirus ELISA Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. IgG

6.2.2. IgM

6.3. Global Cytomegalovirus ELISA Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cytomegalovirus ELISA Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cytomegalovirus ELISA Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cytomegalovirus ELISA Kits Market Competition by Key Manufacturers

8.1. Global Cytomegalovirus ELISA Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cytomegalovirus ELISA Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MyBioSource

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Biomatik

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BosterBio

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbexa

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. DEMEDITEC Diagnostics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. United States Biological

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biorbyt

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Novus Biologicals

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. IBL

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. XpressBio

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Abnova Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Wuhan Fine Biotech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cytomegalovirus ELISA Kits Market

Figure 4: Global Cytomegalovirus ELISA Kits Market: Drivers

Figure 5: Global Cytomegalovirus ELISA Kits Market: Challenges

Figure 6: Global Cytomegalovirus ELISA Kits Market: Trends

Figure 7: Global Cytomegalovirus ELISA Kits Market: Opportunity

Figure 8: Global Cytomegalovirus ELISA Kits Market: Restraint

Figure 9: Global Cytomegalovirus ELISA Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cytomegalovirus ELISA Kits Market Value (USD Million) By Region

Figure 15: Global Cytomegalovirus ELISA Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cytomegalovirus ELISA Kits Market Value (USD Million) By Region

Figure 23: Global Cytomegalovirus ELISA Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Cytomegalovirus ELISA Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cytomegalovirus ELISA Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cytomegalovirus ELISA Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cytomegalovirus ELISA Kits Market Value (USD Million) By Region

Table 10: Global Cytomegalovirus ELISA Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cytomegalovirus ELISA Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cytomegalovirus ELISA Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cytomegalovirus ELISA Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MyBioSource Basic Information And Sales Area

Table 31: MyBioSource. Products Portfolio

Table 32: Biomatik Basic Information And Sales Area

Table 33: Biomatik. Products Portfolio

Table 34: BosterBio Basic Information And Sales Area

Table 35: BosterBio. Products Portfolio

Table 36: Abbexa Basic Information And Sales Area

Table 37: Abbexa. Products Portfolio

Table 38: DEMEDITEC Diagnostics Basic Information And Sales Area

Table 39: DEMEDITEC Diagnostics. Products Portfolio

Table 40: United States Biological Basic Information And Sales Area

Table 41: United States Biological. Products Portfolio

Table 42: Biorbyt Basic Information And Sales Area

Table 43: Biorbyt. Products Portfolio

Table 44: Novus Biologicals Basic Information And Sales Area

Table 45: Novus Biologicals. Products Portfolio

Table 46: IBL Basic Information And Sales Area

Table 47: IBL. Products Portfolio

Table 48: XpressBio Basic Information And Sales Area

Table 49: XpressBio. Products Portfolio

Table 50: Abnova Corporation Basic Information And Sales Area

Table 51: Abnova Corporation. Products Portfolio

Table 52: Wuhan Fine Biotech Basic Information And Sales Area

Table 53: Wuhan Fine Biotech. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Cytomegalovirus ELISA Kits Market Value (USD Million) By Region

Table 59: Global Cytomegalovirus ELISA Kits Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Cytomegalovirus ELISA Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MyBioSource; Biomatik; BosterBio; Abbexa; DEMEDITEC Diagnostics; United States Biological; Biorbyt; Novus Biologicals; IBL; XpressBio; Abnova Corporation; Wuhan Fine Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options